Intrinsic Value of S&P & Nasdaq Contact Us

Omeros Corporation OMER NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.00
+237.8%

Omeros Corporation (OMER) — Analyst outlook / Analyst consensus target is. Based on 19 analyst ratings, the consensus is bullish — 1 Strong Buy, 10 Buy, 6 Hold, 2 Sell.

The consensus price target is $40.00, representing an upside of 237.8% from the current price $11.84.

Analysts estimate Earnings Per Share (EPS) of $-2.93 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.70 vs est $-2.93 (beat +7.9%). 2025: actual $-0.05 vs est $-2.03 (beat +97.4%). Analyst accuracy: 0%.

OMER Stock — 12-Month Price Forecast

$40.00
▲ +237.84% Upside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for Omeros Corporation, the price target is $40.00.
The average price target represents a +237.84% change from the last price of $11.84.

OMER Analyst Ratings

Buy
19
Ratings
11 Buy
6 Hold
2 Sell
Based on 19 analysts giving stock ratings to Omeros Corporation in the past 3 months
Rating breakdown
Strong Buy
1 5%
Buy
10 53%
Hold
6 32%
Sell
2 11%
58%
Buy
11 analysts
32%
Hold
6 analysts
11%
Sell
2 analysts

EPS Estimates — OMER

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$2.70 vs Est –$2.93 ▲ 8.6% off
2025 Actual –$0.05 vs Est –$2.03 ▲ 3,756.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — OMER

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message